SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-23-004004
Filing Date
2023-12-29
Accepted
2023-12-29 16:15:45
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-3 zk2330693.htm F-3 849952
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 19647
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 19368
4 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4350
5 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 43148
6 image0.jpg GRAPHIC 4488
7 image00002.jpg GRAPHIC 86761
8 image00005.jpg GRAPHIC 3240
  Complete submission text file 0001178913-23-004004.txt   1067952
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-276323 | Film No.: 231527859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)